Genmab | Capitale Ordinario

Prezzo Delle Azioni
1,832.50
Cambio Giornaliero
-21.00 -1.13%
Mensile
-13.15%
Annuale
14.67%
Q1 Previsione
1,757.86




Capitale Ordinario Cambiamento Data
Agios Pharmaceuticals USD 58.45M 169K 2025-12
Almirall EUR 214.79M 154.21 2025-06
Amarin USD 20.8M 28K 2025-09
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Bayer EUR 982.42M 0 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Demant DKK 210.9M 5.18M 2025-12
Exelixis USD 268.1M 2.03M 2025-09
Fresenius Medical Care EUR 289.85M 3.56M 2025-09
Galapagos EUR 65.9M 0 2025-09
Genmab DKK 10M 56M 2025-03
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
GN Store Nord DKK 145.61M 458.39M 2025-09
GRIFOLS EUR 679.73M 0 2025-09
Hikma Pharmaceutical USD 40M 0 2024-12
Insmed USD 214.26M 1.67M 2025-12
Lonza CHF 72M 0 2024-12
Merck EUR 434.78M 130.22M 2025-06
Novartis USD 1.94B 23.4M 2025-06
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
UCB EUR 584M 0 2024-12


Genmab Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.